nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—ABCB1—adrenal gland cancer	0.959	1	CbGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000176	0.00423	CbGpPWpGaD
Fesoterodine—CHRM5—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000176	0.00422	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000174	0.00419	CbGpPWpGaD
Fesoterodine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000154	0.00371	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000151	0.00363	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00015	0.00361	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000149	0.00358	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000142	0.00342	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000142	0.00341	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00014	0.00338	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000135	0.00325	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.000134	0.00323	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.000134	0.00322	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.000133	0.00319	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000129	0.00311	CbGpPWpGaD
Fesoterodine—CHRM4—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000129	0.0031	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000129	0.0031	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000128	0.00307	CbGpPWpGaD
Fesoterodine—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.000127	0.00307	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000126	0.00304	CbGpPWpGaD
Fesoterodine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000125	0.00301	CbGpPWpGaD
Fesoterodine—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000124	0.00297	CbGpPWpGaD
Fesoterodine—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000123	0.00296	CbGpPWpGaD
Fesoterodine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000122	0.00293	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000121	0.00291	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—GNAS—adrenal gland cancer	0.000116	0.00279	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000115	0.00276	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—GNRHR—adrenal gland cancer	0.000113	0.00272	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000113	0.00271	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—GNAS—adrenal gland cancer	0.000111	0.00267	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00011	0.00264	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—GNRHR—adrenal gland cancer	0.000108	0.00261	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000108	0.00259	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000105	0.00253	CbGpPWpGaD
Fesoterodine—CHRM4—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.000105	0.00252	CbGpPWpGaD
Fesoterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000103	0.00247	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—TSHR—adrenal gland cancer	0.000102	0.00246	CbGpPWpGaD
Fesoterodine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000101	0.00243	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000101	0.00242	CbGpPWpGaD
Fesoterodine—CHRM5—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.000101	0.00242	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—SDHB—adrenal gland cancer	9.95e-05	0.00239	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ZNRF3—adrenal gland cancer	9.89e-05	0.00238	CbGpPWpGaD
Fesoterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	9.82e-05	0.00236	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—TSHR—adrenal gland cancer	9.8e-05	0.00236	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ZNRF3—adrenal gland cancer	9.47e-05	0.00228	CbGpPWpGaD
Fesoterodine—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	8.58e-05	0.00206	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	8.52e-05	0.00205	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	8.5e-05	0.00204	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	8.49e-05	0.00204	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	8.41e-05	0.00202	CbGpPWpGaD
Fesoterodine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	8.19e-05	0.00197	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	7.82e-05	0.00188	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—POMC—adrenal gland cancer	7.81e-05	0.00188	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	7.79e-05	0.00187	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	7.74e-05	0.00186	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	7.72e-05	0.00186	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	7.71e-05	0.00185	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	7.64e-05	0.00184	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	7.63e-05	0.00183	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	7.61e-05	0.00183	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	7.59e-05	0.00183	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	7.57e-05	0.00182	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	7.53e-05	0.00181	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	7.5e-05	0.0018	CbGpPWpGaD
Fesoterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	7.5e-05	0.0018	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—POMC—adrenal gland cancer	7.48e-05	0.0018	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—PRKACA—adrenal gland cancer	7.34e-05	0.00177	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	7.09e-05	0.00171	CbGpPWpGaD
Fesoterodine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	7.08e-05	0.0017	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	7.07e-05	0.0017	CbGpPWpGaD
Fesoterodine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	7.05e-05	0.0017	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	7.04e-05	0.00169	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—PRKACA—adrenal gland cancer	7.03e-05	0.00169	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	7e-05	0.00168	CbGpPWpGaD
Fesoterodine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	6.99e-05	0.00168	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	6.91e-05	0.00166	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	6.9e-05	0.00166	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	6.89e-05	0.00166	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	6.87e-05	0.00165	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—CDC42—adrenal gland cancer	6.86e-05	0.00165	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	6.82e-05	0.00164	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	6.81e-05	0.00164	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—GNRH1—adrenal gland cancer	6.78e-05	0.00163	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	6.67e-05	0.0016	CbGpPWpGaD
Fesoterodine—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	6.65e-05	0.0016	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	6.65e-05	0.0016	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	6.58e-05	0.00158	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—CDC42—adrenal gland cancer	6.57e-05	0.00158	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—GNAS—adrenal gland cancer	6.55e-05	0.00158	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—GNRH1—adrenal gland cancer	6.49e-05	0.00156	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—SDHD—adrenal gland cancer	6.41e-05	0.00154	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—RRM1—adrenal gland cancer	6.41e-05	0.00154	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—SDHB—adrenal gland cancer	6.31e-05	0.00152	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—GNAS—adrenal gland cancer	6.27e-05	0.00151	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—CDC42—adrenal gland cancer	6.23e-05	0.0015	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SPRY2—adrenal gland cancer	6.2e-05	0.00149	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TSHR—adrenal gland cancer	6.04e-05	0.00145	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—CDC42—adrenal gland cancer	5.96e-05	0.00143	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—GNAS—adrenal gland cancer	5.95e-05	0.00143	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	5.95e-05	0.00143	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SPRY2—adrenal gland cancer	5.94e-05	0.00143	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TSHR—adrenal gland cancer	5.79e-05	0.00139	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—GNAS—adrenal gland cancer	5.7e-05	0.00137	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MEN1—adrenal gland cancer	5.68e-05	0.00137	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MEN1—adrenal gland cancer	5.44e-05	0.00131	CbGpPWpGaD
Fesoterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	5.28e-05	0.00127	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	5.26e-05	0.00127	CbGpPWpGaD
Fesoterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	5.26e-05	0.00127	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	5.25e-05	0.00126	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	5.2e-05	0.00125	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	5.18e-05	0.00124	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	4.95e-05	0.00119	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	4.93e-05	0.00119	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	4.89e-05	0.00118	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—MED12—adrenal gland cancer	4.78e-05	0.00115	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	4.72e-05	0.00114	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	4.68e-05	0.00112	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	4.63e-05	0.00111	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	4.62e-05	0.00111	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	4.61e-05	0.00111	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	4.57e-05	0.0011	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	4.56e-05	0.0011	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	4.56e-05	0.0011	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	4.51e-05	0.00109	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	4.42e-05	0.00106	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—POMC—adrenal gland cancer	4.41e-05	0.00106	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	4.4e-05	0.00106	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	4.36e-05	0.00105	CbGpPWpGaD
Fesoterodine—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	4.35e-05	0.00105	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PRKACA—adrenal gland cancer	4.34e-05	0.00104	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—POMC—adrenal gland cancer	4.22e-05	0.00102	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	4.2e-05	0.00101	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	4.19e-05	0.00101	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	4.18e-05	0.00101	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	4.17e-05	0.001	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PRKACA—adrenal gland cancer	4.15e-05	0.000999	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	4.14e-05	0.000997	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	4.13e-05	0.000992	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	4.07e-05	0.00098	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—RRM1—adrenal gland cancer	4.07e-05	0.000978	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—SDHD—adrenal gland cancer	4.07e-05	0.000978	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	4.06e-05	0.000977	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	4.02e-05	0.000967	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	4.01e-05	0.000965	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—POMC—adrenal gland cancer	4.01e-05	0.000963	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	4e-05	0.000962	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	3.96e-05	0.000952	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SDHB—adrenal gland cancer	3.89e-05	0.000935	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—POMC—adrenal gland cancer	3.84e-05	0.000923	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	3.83e-05	0.000922	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	3.83e-05	0.000922	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	3.83e-05	0.000921	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.83e-05	0.00092	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	3.82e-05	0.000918	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	3.78e-05	0.000909	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CDC42—adrenal gland cancer	3.68e-05	0.000885	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	3.67e-05	0.000883	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IGF2—adrenal gland cancer	3.55e-05	0.000853	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CDC42—adrenal gland cancer	3.52e-05	0.000847	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—GNAS—adrenal gland cancer	3.51e-05	0.000845	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PRKACA—adrenal gland cancer	3.49e-05	0.000838	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IGF1R—adrenal gland cancer	3.43e-05	0.000824	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IGF2—adrenal gland cancer	3.4e-05	0.000816	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—GNAS—adrenal gland cancer	3.37e-05	0.000809	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IGF1R—adrenal gland cancer	3.28e-05	0.000789	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.08e-05	0.000741	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—MED12—adrenal gland cancer	3.03e-05	0.000729	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	2.97e-05	0.000715	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	2.97e-05	0.000713	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TERT—adrenal gland cancer	2.95e-05	0.00071	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	2.94e-05	0.000706	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	2.92e-05	0.000703	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	2.91e-05	0.000701	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	2.89e-05	0.000694	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—MED12—adrenal gland cancer	2.86e-05	0.000687	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TERT—adrenal gland cancer	2.83e-05	0.00068	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GNAS—adrenal gland cancer	2.83e-05	0.000679	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ABCB1—adrenal gland cancer	2.77e-05	0.000667	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	2.7e-05	0.00065	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	2.69e-05	0.000648	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	2.67e-05	0.000641	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	2.57e-05	0.000617	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	2.51e-05	0.000602	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	2.51e-05	0.000602	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	2.48e-05	0.000596	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	2.47e-05	0.000595	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	2.46e-05	0.000591	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	2.45e-05	0.000589	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	2.39e-05	0.000575	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	2.38e-05	0.000573	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	2.37e-05	0.00057	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	2.37e-05	0.000569	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	2.36e-05	0.000568	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	2.36e-05	0.000568	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	2.34e-05	0.000563	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	2.34e-05	0.000562	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	2.31e-05	0.000556	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	2.3e-05	0.000554	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	2.28e-05	0.000549	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	2.27e-05	0.000545	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	2.27e-05	0.000545	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	2.24e-05	0.000538	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.21e-05	0.000532	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	2.17e-05	0.000522	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	2.08e-05	0.000501	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	1.99e-05	0.000478	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	1.98e-05	0.000477	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	1.96e-05	0.000472	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—POMC—adrenal gland cancer	1.9e-05	0.000457	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.87e-05	0.000449	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.79e-05	0.000431	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	1.73e-05	0.000416	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	1.73e-05	0.000415	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	1.71e-05	0.000411	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	1.69e-05	0.000406	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	1.69e-05	0.000406	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	1.66e-05	0.000399	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	1.62e-05	0.000389	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	1.6e-05	0.000384	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	1.59e-05	0.000383	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	1.58e-05	0.000379	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	1.58e-05	0.000379	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	1.57e-05	0.000378	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	1.56e-05	0.000374	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	1.53e-05	0.000367	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	1.52e-05	0.000366	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PTGS2—adrenal gland cancer	1.52e-05	0.000365	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	1.51e-05	0.000363	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.36e-05	0.000328	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	1.34e-05	0.000322	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	1.28e-05	0.000308	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—POMC—adrenal gland cancer	1.21e-05	0.00029	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.14e-05	0.000274	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.14e-05	0.000274	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	1.14e-05	0.000273	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.12e-05	0.00027	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	1.12e-05	0.00027	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.1e-05	0.000266	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.08e-05	0.000261	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	1.08e-05	0.000259	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	9.63e-06	0.000232	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	9.07e-06	0.000218	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	9.02e-06	0.000217	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	8.99e-06	0.000216	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	8.91e-06	0.000214	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	7.58e-06	0.000182	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	7.55e-06	0.000182	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	7.48e-06	0.00018	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—POMC—adrenal gland cancer	7.44e-06	0.000179	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	5.93e-06	0.000143	CbGpPWpGaD
